# Airna funding rounds and investors

As of 14 Oct 2026, Airna has raised $155M across 1 verified round on record; latest: $155 million Series B led by Forbion Growth and Venrock Healthcare Capital Partners, announced Apr 2025.

AIRNA develops RNA editing therapeutics aimed at delivering functional cures for patients with rare diseases and common conditions.

Website: https://airna.com  
Headquarters: Cambridge, MA, USA  
Page: https://fireround.dev/companies/airna.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-04 | Series B | $155 million | Forbion Growth, Venrock Healthcare Capital Partners | Arch Venture Partners, ND Capital, Nextech Invest, RTW Investments | [airna.com](https://airna.com/news/airna-raises-oversubscribed-155-million-series-b-financing-to-fund-phase-1-2-clinical-trial-for-alpha-1-antitrypsin-deficiency-and-future-pipeline) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.